Form 4 holding
Reporting Person's title: EVP, Chief Commercial Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 175,178
- Estimated value
- $4,539,720
- Report date
- 02 Mar 2026
- Price
- $25.91
- Ownership
- Direct